Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

drug resistance

  • You have access
    NSUN7 Suppression Reduces Metastatic Potential and Restores Sensitivity to 4-OH Tamoxifen in Resistant MCF-7 Cells
    SANA MAHMOOD, ANDREI V. CHERNOV, SEHRISH KHAN, RAMAMURTHY CHITTETI, SALMMA SALAMAH SALIHAH, SOHAIL A. QURESHI, HEMAL H. PATEL and ASMA GUL
    Anticancer Research December 2025, 45 (12) 5321-5339; DOI: https://doi.org/10.21873/anticanres.17871
  • You have access
    Antitumor Potential of Epigallocatechin Gallate in Overcoming Molecular Therapy Resistance in Hepatocellular Carcinoma
    ATSUO KITAOKA, KYOKO OURA, KOJI FUJITA, KOTA SASAKI, FUMIYUKI SUETSUGU, MAI NAKAHARA, TOMOKO TADOKORO, SHIMA MIMURA, JOJI TANI, ASAHIRO MORISHITA, ERIKA OMAYU, HISAKAZU IWAMA, TSUTOMU MASAKI and HIDEKI KOBARA
    Anticancer Research October 2025, 45 (10) 4211-4229; DOI: https://doi.org/10.21873/anticanres.17773
  • You have access
    Synergistic Effect of Antimicrobial Resistance and Cytogenetic Risk on Mortality in Acute Myeloid Leukemia
    DEIVIDE DE SOUSA OLIVEIRA, FLÁVIA MELO CUNHA DE PINHO PESSOA, ISADORA LIMA PONTES, KAIRA MARA DE ALBUQUERQUE CORDEIRO, BEATRIZ MARIA DIAS NOGUEIRA, GUILHERME PASSOS DE MORAIS, RODRIGO MONTEIRO RIBEIRO, FABIANA AGUIAR CARNEIRO SILVA, LÍVIA ANDRADE GURGEL, MANOEL ODORICO DE MORAES FILHO, MARIA ELISABETE AMARAL DE MORAES and CAROLINE AQUINO MOREIRA-NUNES
    Anticancer Research August 2025, 45 (8) 3295-3304; DOI: https://doi.org/10.21873/anticanres.17690
  • Open Access
    Ivermectin Enhances Paclitaxel Efficacy by Overcoming Resistance Through Modulation of ABCB1 in Non-small Cell Lung Cancer
    ANNA HAYASHI, KOICHIRO KAMIO, AKIHIKO MIYANAGA, KEISUKE YOSHIDA, RINTARO NORO, KUNIKO MATSUDA, TAKEHIRO TOZUKA, MIWAKO OMORI, MARIKO HIRAO, AYA FUKUIZUMI, KAKERU HISAKANE, SUSUMU TAKEUCHI, MASARU MATSUMOTO, KAZUO KASAHARA, TAKANORI AMANO, KAZUFUMI HONDA and MASAHIRO SEIKE
    Anticancer Research December 2024, 44 (12) 5271-5282; DOI: https://doi.org/10.21873/anticanres.17355
  • You have access
    Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma
    SONEXAI KIDOIKHAMMOUAN, WORACHART LERT-ITTHIPORN, RAKSAWAN DEENONPOE, CHARUPONG SAENGBOONMEE, SUMALEE OBCHOEI, SOPIT WONGKHAM and WUNCHANA SEUBWAI
    Anticancer Research December 2024, 44 (12) 5393-5404; DOI: https://doi.org/10.21873/anticanres.17366
  • Open Access
    Lymphocyte Antigen 6 Family Member D (LY6D) Affects Stem Cell Phenotype and Progression of Pancreatic Adenocarcinoma
    SHUMPEI OKIMURA, NAOHIRO NISHIDA, HIDEKAZU TAKAHASHI, YUHKI YOKOYAMA, HIROYUKI YAMAMOTO, ATSUSHI HAMABE, TAKAYUKI OGINO, NORIKATSU MIYOSHI, HIDENORI TAKAHASHI, MAMORU UEMURA, SHOGO KOBAYASHI, MASAKI MORI, YUICHIRO DOKI, HIDETOSHI EGUCHI and HIROFUMI YAMAMOTO
    Anticancer Research November 2024, 44 (11) 4737-4749; DOI: https://doi.org/10.21873/anticanres.17300
  • You have access
    MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma
    MINJI KWON, DAYEON LIM, JAYEON PARK, WORLD GIL, JIWOO JUNG, SUYEON JUNG, CHAEEON KIM, MINJEONG GO, YE HWANG CHEONG, HEE SUN PARK, YONG-BIN EOM and SIN-AYE PARK
    Anticancer Research October 2024, 44 (10) 4283-4299; DOI: https://doi.org/10.21873/anticanres.17258
  • Open Access
    Identification of BRAF Inhibitor Resistance–associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening
    XUAN WEN, MIN HAN, MASAKI HOSOYA, RIKA TOSHIMA, MAI ONISHI, TOMOAKI FUJII, SHIGEO YAMAGUCHI and SHUNSUKE KATO
    Anticancer Research June 2024, 44 (6) 2349-2358; DOI: https://doi.org/10.21873/anticanres.17042
  • You have access
    Caffeic Acid Enhances Anticancer Drug-induced Apoptosis in Acid-adapted HCT116 Colon Cancer Cells
    SUNG-CHUL LIM, TAE-BUM LEE and SONG IY HAN
    Anticancer Research June 2024, 44 (6) 2587-2595; DOI: https://doi.org/10.21873/anticanres.17064
  • Open Access
    High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy
    TAKASHI HIGUCHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, SHINJI MIWA, KENTARO IGARASHI, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Anticancer Research October 2023, 43 (10) 4277-4284; DOI: https://doi.org/10.21873/anticanres.16622

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire